115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long survival in patients with adnexal high-grade serous carcinoma who underwent suboptimal cytoreductive surgery: A whole-genome analysis
    Meeting Abstract

    Sullivan, M.; Brown, D.; Paula, A. D.; Boerner, T.; O'Cearbhaill, R.; Tew, W.; Grisham, R.; Sonoda, Y.; Leitao, M.; Broach, V.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Impact of hyperthermic intraperitoneal chemotherapy at time of secondary cytoreductive surgery on immediate platinum resistance: A Memorial Sloan Kettering team ovary study
    Meeting Abstract

    Praiss, A.; Donohoe, F.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Broach, V.; Al-Niaimi, A.; Gardner, G.; Roche, K. L.; O'Cearbhaill, R.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53WT advanced or recurrent endometrial cancer: Follow up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Fidalgo, J. A. P.; Vergote, I.; Hamilton, E.; Giorgi, U. D.; Gorp, T. V.; Lübbe, K.; Zikan, M.; Helpman, L.; Miller, D. S.; Fariñas-Madrid, L.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial
    Meeting Abstract

    You, B.; Anderson, C.; Cecere, S. C.; Carrot, A.; Myers, T.; Heitz, F.; Sudarshan, S.; Selcukbiricik, F.; Aghajanian, C.; Fernebro, J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of therapy in patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-ov81/NCRI/RAMP 301
    Meeting Abstract

    Grisham, R.; Monk, B.; Van Nieuwenhuysen, E.; Moore, K.; Fabbro, M.; O'Malley, D.; Oaknin, A.; Thaker, P.; Oza, A.; Colombo, N.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Randomized, phase II/III study of pegylated liposomal doxorubicin, bevacizumab, and atezolizumab in platinum-resistant ovarian cancer (NRG-GY009): Clinical outcomes by PD-L1 and T cell infiltration status
    Meeting Abstract

    O'Cearbhaill, R.; Zamarin, D.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
    Meeting Abstract

    Banerjee, S.; Aghajanian, C.; Van Nieuwenhuysen, E.; Santin, A.; Ring, K.; Colombo, N.; Thaker, P.; Prendergast, E.; Moore, K.; Chon, H. S.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Extracting phenotypes from clinical descriptions using large language models: A comparison between automated and manual approach
    Meeting Abstract

    Berardelli, S.; Gazzo, A.; De Paoli, F.; Limongelli, I.; Rizzo, E.; Magni, P.; Zucca, S.
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • The spectrum of SMARCB1-deficient tumors extends to T-cell lymphomas enriched in children and young adults
    Meeting Abstract

    Fischer, A.; Moreno, N.; Interlandi, M.; Albert, T. K.; Marmann, J.; Glaser, S.; Verma, A.; Patil, P.; Balbach, S. T.; Wagener, R.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Deciphering the gene expression signature of high-grade B-cell lymphomas with 11q aberrations
    Meeting Abstract

    Chteinberg, E.; Di Stefano, G.; Löffler-Wirth, H.; Staiger, A. M.; Hillebrecht, S.; Wagener, R.; Bens, S.; Oehl-Huber, K.; Dahlum, S.; Abramov, D.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save